Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Precise-engineering of monodisperse magnetite nanoparticles with low-level of cobalt doping for enhanced MRI contrast performance

  • Nistor, Mirela
  • Balan, Vera
  • Pui, Aurel
  • Zară-Dănceanu, Camelia Mihaela
  • Postu, Paula Alexandra
  • Grigoraş, Marian
  • Gherca, Daniel
  • Toma, Valentin
  • Uritu, Cristina Mariana
  • Fratila, Raluca M.
  • Stiufiuc, Rares-Ionut
  • Dragoi, Brindusa
Herein, we designed and synthesized cobalt-modified magnetite nanoparticles (MNPs) in an environmentally safe aqueous medium by using biocompatible Pluronic F127 as dispersant without altering the Fe3+/Fe2+ stoichiometric ratio of 2:1. Gradually increasing amounts of cobalt (1, 5, 10 mol %) were added to this formulation. The obtained MNPs were systematically characterized for their physico-chemical and magnetic properties by ICP-OES, XRD, TEM/EDX, FT-IR, RAMAN, XPS, DLS, Zeta potential, and VSM. Our method ensured that iron oxidation states and their stoichiometry remain unchanged while incorporation of Co was successfully achieved with Co2+ as the oxidation state, according to XPS. XRD confirmed the inverse spinel structure with cobalt ions mainly occupying the interstitial sites although RAMAN revealed a slight contribution of normal spinel. TEM revealed nanoparticles of ∼ 11.8 nm, displaying a mixed sphere- and cubic-like morphology while DLS and Zeta showed some Co-induced agglomeration and a shift toward positive values, respectively. In vitro cytotoxicity tests indicated good preliminary biocompatibility for all samples. Co-modified MNPs showed enhanced r2 values in agarose phantoms on 1T MRI apparatus. These outcomes obviously indicate that cobalt-modified magnetite have promising practical implications, being suitable for cancer diagnosis and recommending further in vivo evaluation (e.g, toxicity, biodistribution, immune-response studies)., This work was supported by two grants: H2020 grant – ERA-Chair, no. 952390/2020 and one of the Romanian Ministry of Research, Innovation and Digitalization, CNCS - UEFISCDI, PN-III-P3-3.6-H2020-2020-0105, no. 35/2021. R. M. F acknowledges support from grant CNS2023-144436 funded by MICIU/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR” and from the European Commission (TBMED project, DT-NMBP-02-2018, grant agreement 814439)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Precise-engineering of monodisperse magnetite nanoparticles with low-level of cobalt doping for enhanced MRI contrast performance

  • Nistor, Mirela
  • Balan, Vera
  • Pui, Aurel
  • Zara-Danceanu, Camelia Mihaela
  • Postu, Paula Alexandra
  • Grigoras, Marian
  • Gherca, Daniel
  • Toma, Valentin
  • Uritu, Cristina Mariana
  • Fratila, Raluca M.
  • Stiufiuc, Rares-Ionut
  • Dragoi, Brindusa
Herein, we designed and synthesized cobalt-modified magnetite nanoparticles (MNPs) in an environmentally safe aqueous medium by using biocompatible Pluronic F127 as dispersant without altering the Fe3+/Fe2+ stoichiometric ratio of 2:1. Gradually increasing amounts of cobalt (1, 5, 10 mol %) were added to this formulation. The obtained MNPs were systematically characterized for their physico-chemical and magnetic properties by ICP-OES, XRD, TEM/EDX, FT-IR, RAMAN, XPS, DLS, Zeta potential, and VSM. Our method ensured that iron oxidation states and their stoichiometry remain unchanged while incorporation of Co was successfully achieved with Co2+ as the oxidation state, according to XPS. XRD confirmed the inverse spinel structure with cobalt ions mainly occupying the interstitial sites although RAMAN revealed a slight contribution of normal spinel. TEM revealed nanoparticles of ~ 11.8 nm, displaying a mixed sphere- and cubic-like morphology while DLS and Zeta showed some Co-induced agglomeration and a shift toward positive values, respectively. In vitro cytotoxicity tests indicated good preliminary biocompatibility for all samples. Co-modified MNPs showed enhanced r2 values in agarose phantoms on 1T MRI apparatus. These outcomes obviously indicate that cobalt-modified magnetite have promising practical implications, being suitable for cancer diagnosis and recommending further in vivo evaluation (e.g, toxicity, biodistribution, immune-response studies).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Design and Physicochemical Characterization of a Multifunctional Maisine-Based Microemulsion Incorporating Doxorubicin@Mn-Doped Magnetite Nanoparticles for MRI, Hyperthermia, and Drug Delivery

  • Nistor, Mirela
  • Gherca, Daniel
  • Uritu, Cristina Mariana
  • Grigoras, Marian
  • Balan, Vera
  • Fratila, Raluca M.
  • Stiufiuc, Rares-Ionut
  • Dragoi, Brindusa
  • Pui, Aurel
Multifunctional nanocarriers capable of integrating imaging, magnetic functionality, and controlled drug delivery represent an important research topic in cancer nanomedicine. Herein, Mn-doped (Fe3O4) magnetite nanoparticles (MNPs) were engineered and incorporated into a Maisine CC-based oil-in-water microemulsion (ME) to obtain a multifunctional nanoplatform for magnetic resonance imaging (MRI), hyperthermia, and controlled drug release. A series of Mn-doped MNPs (1–10% Mn:Fe3O4) was synthesized by coprecipitation. X-ray diffraction confirmed the preservation of the cubic spinel upon Mn incorporation. The Mn incorporation resulted in MNPs made of crystallites (~9–12 nm) whose magnetic properties were improved. Also, 10% Mn led to a very good magnetic heating efficiency under alternating magnetic fields with a specific absorption rate of ~111 W·g−1. The obtained MNPs proved to be T2-weighted MRI contrast agents, with an increase in the r2 values up to ~844 mM−1·s−1 after incorporation into ME. The optimized composition of Mn10% was subsequently loaded with doxorubicin (DOX) and integrated into ME. Drug-release studies revealed a biphasic profile, characterized by an initial burst phase followed by sustained release up to 48 h. These findings demonstrate that dopant-engineered MNPs combined with a ME carrier can provide a versatile platform for integrating magnetic hyperthermia potential, T2-weighted MRI contrast enhancement, and controlled chemotherapeutic delivery within a single nanostructured system.